XU Rong-long, HE Hai-lang, TANG Jie, et al. Meta-analysis on Treatment of Non-small Cell Lung Cancer with Aidi Injection in Combination with Radiothreapy[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(6): 204-209.
DOI:
XU Rong-long, HE Hai-lang, TANG Jie, et al. Meta-analysis on Treatment of Non-small Cell Lung Cancer with Aidi Injection in Combination with Radiothreapy[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(6): 204-209. DOI: 10.13422/j.cnki.syfjx.2015060204.
Meta-analysis on Treatment of Non-small Cell Lung Cancer with Aidi Injection in Combination with Radiothreapy
Objective: The aim of this article was to study the efficacy and safety of Aidi injection in combination with radiotherapy in treating non-small cell lung cancer (NSCLC). Method: Cochrane Library
PubMed
CBM
CNKI
VIP and WANFANG DATA were screened. The retrieval time was from the establishment time of each database to May 2014.Randomized controlled trials (RCTs) of Aidi injection in combination with radiotherapy in any language were included. Two researchers extracted data and assessed the literature quality separatedly
and made a Meta-analysis by RevMan 5.2 software. Result: 10 RCTs involving 678 patients entered the inclusion criteria. The meta-analysis showed that compared with pure application of radiotherapy
Aidi injection in combination with radiotherapy can enhance the short-term curative effect [OR=4.00
95%CI(2.86
5.60)
P<0.000 01]
and improve the quality of life [OR=4.99
95%CI(3.02
8.26)
P<0.000 01]
decrease the incidence of radiation pneumonitis [RR=0.46
95%CI(0.34
0.63)
P<0.000 01] radiation esophagitis [RR=0.49
95%CI(0.37
0.66)
P<0.000 01] and the bone marrow suppression [RR=0.51
95%CI(0.38
0.69)
P<0.000 01]. Conclusion: Aidi injection in combination with radiotherapy can not only enhance the short-term curative effect
but also improve the quality of life
and decrease the incidence of radiation pneumonitis
radiation esophagitis and bone marrow suppression. However
the quality of RCTs is low
so more clinical trials in high quality were needed to study.